Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volociximab and liposomal doxorubicin in advanced ovarian or primary peritoneal cancer
NCT00635193Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Countries
- 9
01
Overview
A Phase 2 trial of volociximab in ovarian cancer, primary peritoneal cancer (PPC), sponsored by AbbVie Inc.. Started Jul 2007; status: completed.
02
Drugs
volociximab
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00635193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635193.